📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
📉 Score Deterioration
15%
• Score climbed 5 points (worsening)
💹 Market Data
Market Cap$21.72B
Shares Outstanding110.70M
Float110.08M
Cash$393.00M
Debt$6.41B
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 3.3% shares (2025Q4 vs prior)
1041 institutional holders · 112.39M shares
#1
VANGUARD GROUP INC
14.39M shares
#2
BlackRock, Inc.
9.46M shares
#3
PRICE T ROWE ASSOCIATES INC /MD/
6.30M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest3.39M
Days to Cover2.6
% of Float3.1%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
Apr 24, 2026
4
INSIDER TRANSACTION
Apr 24, 2026
4
INSIDER TRANSACTION
Apr 24, 2026
4
INSIDER TRANSACTION
Apr 24, 2026
4
INSIDER TRANSACTION
Apr 24, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for DGX
📊 DGX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 DGX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.